Susan Rodriguez

Chief Commercial Officer, Ardelyx (United States).

Companies

Monopar TherapeuticsCCSO Mar 4, 2026 to now¹
Avadel PharmaceuticalsChief operating officer May 13, 2025 to now²
Veradigm Inc.Board member Feb 27, 2023 to now³
HERON THERAPEUTICS, INC. /DE/Board member Sep 29, 2021 to Feb 4, 2025⁴
Ardelyx (United States)Chief Commercial Officer May 19, 2020 to May 23, 2024⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Ardelyx (United States) ARDX449,092 shares⁶$1.4M at $3.09May 21, 2024
HERON THERAPEUTICS, INC. /DE/ HRTX87,180 shares⁷$33.1K at $0.38Jan 31, 2025
Veradigm Inc.131,125 shares⁸Jun 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 1, 2026Granted 42,507 shares of Veradigm Inc.⁸
Jun 2, 2025Granted 46,512 shares at $4.30 of Veradigm Inc.⁹
Jan 31, 2025Granted 17,950 shares of HERON THERAPEUTICS, INC. /DE/⁷
Jan 30, 2025Granted 17,950 shares of HERON THERAPEUTICS, INC. /DE/¹⁰
May 31, 2024Granted 42,106 shares of Veradigm Inc.¹¹
May 21, 2024Sold 6,703 shares at $7.81 of Ardelyx (United States)⁶
Feb 20, 2024Sold 6,928 shares at $8.75 of Ardelyx (United States)¹²
Jan 19, 2024Granted 13,948 shares of HERON THERAPEUTICS, INC. /DE/¹³
Jan 16, 2024Granted 112,750 shares of Ardelyx (United States)¹⁴
Nov 20, 2023Sold 4,714 shares at $4.36 of Ardelyx (United States)¹⁵
Aug 21, 2023Sold 4,733 shares at $3.55 of Ardelyx (United States)¹⁶
May 23, 2023Sold 4,711 shares at $3.65 of Ardelyx (United States)¹⁷
Feb 21, 2023Sold 5,586 shares at $3.00 of Ardelyx (United States)¹⁸
Jan 5, 2023Granted 78,000 shares of Ardelyx (United States)¹⁹
Dec 16, 2022Granted 38,580 shares of HERON THERAPEUTICS, INC. /DE/²⁰
Nov 22, 2022Sold 3,303 shares at $1.95 of Ardelyx (United States)²¹
Nov 22, 2022Sold 22 shares at $1.95 of Ardelyx (United States)²¹
Nov 22, 2022Sold 131 shares at $1.94 of Ardelyx (United States)²¹
Aug 22, 2022Sold 64 shares at $0.98 of Ardelyx (United States)²²
Aug 22, 2022Sold 3,356 shares at $0.98 of Ardelyx (United States)²²
Jun 6, 2022Sold 910 shares at $0.64 of Ardelyx (United States)²³
Jun 6, 2022Sold 43,010 shares at $0.65 of Ardelyx (United States)²³
May 20, 2022Sold 3,425 shares at $0.67 of Ardelyx (United States)²⁴
Feb 22, 2022Sold 3,400 shares at $0.67 of Ardelyx (United States)²⁵
Jan 6, 2022Granted 141,000 shares of Ardelyx (United States)²⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARMonopar Therapeutics, CCSO
2
SEC EDGARAvadel Pharmaceuticals, Chief operating officer
3
SEC EDGARVeradigm Inc., Board member
4
SEC EDGARHERON THERAPEUTICS, INC. /DE/, Board member
5
SEC EDGARArdelyx (United States), Chief Commercial Officer
6
SEC EDGARArdelyx (United States) shares after the filing of May 21, 2024
7
SEC EDGARHERON THERAPEUTICS, INC. /DE/ shares after the filing of Jan 31, 2025
8
SEC EDGARVeradigm Inc. shares after the filing of Jun 1, 2026
9
SEC EDGARForm 4 filed Jun 3, 2025
10
SEC EDGARForm 4 filed Feb 3, 2025
11
SEC EDGARForm 4 filed Jun 20, 2024
12
SEC EDGARForm 4 filed Feb 22, 2024
13
SEC EDGARForm 4 filed Jan 19, 2024
14
SEC EDGARForm 4 filed Jan 18, 2024
15
SEC EDGARForm 4 filed Nov 22, 2023
16
SEC EDGARForm 4 filed Aug 23, 2023
17
SEC EDGARForm 4 filed May 25, 2023
18
SEC EDGARForm 4 filed Mar 2, 2023
19
SEC EDGARForm 4 filed Jan 6, 2023
20
SEC EDGARForm 4 filed Dec 20, 2022
21
SEC EDGARForm 4 filed Nov 23, 2022
22
SEC EDGARForm 4 filed Aug 24, 2022
23
SEC EDGARForm 4 filed Jun 8, 2022
24
SEC EDGARForm 4 filed May 23, 2022
25
SEC EDGARForm 4 filed Feb 25, 2022
26
SEC EDGARForm 4 filed Jan 12, 2022